Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FRMI vs GSK✓SelectedUSD · GSKFRMI vs GSK performance historyLatest closeAs of-4.98%11/16
Stock and ETF performance explorer

FRMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-92.4%
GSK return
+19.1%
Excess return
-111.5%
Maximum drawdown
-95.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.0%-0.1%-4.9%-5.0%
7D+49.4%-1.3%+50.7%+48.2%
30D-21.5%+2.7%-24.3%-19.7%
3M-61.3%+2.7%-64.0%-59.8%
6M-61.9%+3.3%-65.2%-60.5%
YTD-69.0%+6.5%-75.5%-65.6%
1Y-86.4%+10.7%-97.1%-84.3%
All-92.4%+19.1%-111.5%-90.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling